Association study of FTOgene polymorphism with weight gain associated with 4 week risperidone treatment

WANG Fang,MI Wei-Feng,LU Tian-Lan,RUAN Yan-Yan,ZHANG Dai,YUE Wei-Hua
DOI: https://doi.org/10.3969/j.issn.1000-6729.2013.02.017
2013-01-01
Abstract:Objectives:To explore the association between the Fat Mass and Obesity Associated(FTO) gene polymorphism and weight gain associated with risperidone treatment.Methods:Totally 236 schizophrenic patients met the Diagnostic and Statistical Manual of Mental Disorders,Fourth Edition(DSM-IV) criteria were enrolled in our study.All the patients were treated with risperidone.The body weight and height of the patients were measured before and after 4week risperidone treatment to calculate body mass index.The FTO rs9939609 polymorphism was genotyped by using direct DNA sequencing method,and was analyzed for association with risperidone-induced weight gain.Results:There was no significant association between rs9939609 and baseline BMIP>0.05] and rs9939609 was neither associated with 4-week BMI P>0.05].There was a significant association between rs9939609 of FTO and BMI change,TT-carriers experienced higher BMI gain than AA/AT-carriers [(0.6±1.1) vs.(0.2±1.3),P<0.05].Conclusion:It suggests that FTO gene polymorphism may be associated with weight gain associatied with risperidone treatment in this Chinese Han population.
What problem does this paper attempt to address?